Our expert for hiPSC-derived cardiac cells, as well as cell-based assays & services for drug safety and efficacy screenings
We offer human iPSC-derived cardiomyocytes optimized for use in combination with the Maestro™ MEA System. Combining these technologies enables detailed electrophysiological detection of potential cardioactive and proarrhythmic effects of test compounds in 48- and 96-well plate formats.
This combination provides a highly relevant in vitro assay platform to study the cardiac safety or efficacy profile of compounds during drug development.
You can find our recommendations on how to combine our cardiomyocytes with the Maestro™ MEA system on 48- and 96-well plate formats for electrophysiology measurements in the following User Guides:
Case studies were performed to assess the effects of cardioactive compounds on the electrophysiology of Pluricyte® Cardiomyocytes using the Maestro™ MEA system. Pluricyte® Cardiomyocytes show the expected pharmacological responses to reference compounds in a reproducible manner.